To the best of our knowledge, this is the first time of demonstrating the differential roles of Epac1 and Epac2 in gut permeability changes, inflammation, glucose intolerance, and gut dysbiosis upon WD feeding. Here, RAPGEF3 is linked to Wilson disease.